News

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...
When HHS secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...
A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...
Messenger RNA vaccines have proven to be effective and are safer than standard vaccines, because they have fewer side effects ...
Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics ...
The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...